Substituted imidazopyr- and imidazotri-azines

US8481733B2 · kind B2 · utility

Assignee

• OSI Pharmaceuticals, LLC · US

Inventors

• Andrew Philip Crew · North Babylon, US
• Meizhong Jin · Dix Hills, US
• Mridula Kadalbajoo · Farmingdale, US
• Andrew Kleinberg · Roslyn Heights, US
• Mark J. Mulvihill · Melville, US
• Jing Wang · Acton, US

Key dates

• Filing date: May 19, 2009
• Grant date: Jul 9, 2013
• Expiry date: Oct 22, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Fused pyridine-based bicyclic compounds having the structure of Formula I, as defined herein, pharmaceutically acceptable salts thereof, preparation, compositions, and disease treatment therewith. This abstract does not define or limit the invention.